Tucatinib is an anticancer medication used for the treatment of HER2-positive breast cancer. It is a…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Selumetinib is a prescription medicine that is used to treat children 2 years of age and…
Ivosidenib is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. Ivosidenib is an anti-cancer medication for the treatment of acute…
HANQUYOU® (Trastuzumab) sold under the brand name 汉曲优® in china, Since its launch, 汉曲优® has been…
Tevimbra (Tislelizumab-jsgr) sold under the brand name 百泽安 in china, is a humanized IgG4 anti–PD-1 monoclonal…
Trelagliptin is an orally active dipeptidyl peptidase (DPP)-4 inhibitor approved in Japan for the treatment of…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
BRUKINSA (Zanubrutinib) sold under the brand name 百悦泽 in china, is a BTK Inhibitor used to…
Ryzneuta® (Efbemalenograstim alfa-vuxw), sold under the brand name 亿立舒® in china, is a leukocyte growth factor used…
Fruquintinib (Fruzaqla) sold under the brand name 爱优特 in china, is an oral, highly selective, small molecule…
Loqtorzi (toripalimab-tpzi) sold under the brand name 拓益 in china, is a next generation anti-PD-1 monoclonal antibody…
Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and…
Avzivi® (Bevacizumab-tnjn) sold under the brand name POBEVCY (普贝希) in China, is a humanized monoclonal antibody…
Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with specific mutations…